LENSAR, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
LNSR Nasdaq 3841 www.lensar.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for LENSAR, Inc.

LENSAR (LNSR) Q2 2026 Earnings Call Transcript - Aug 20th, 2026 8:13 am
LENSAR Inc (LNSR) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability Surge - Aug 13th, 2026 5:07 pm
LENSAR Q2 Earnings Call Highlights - Aug 13th, 2026 11:04 am
LENSAR, Inc. Q2 2026 Earnings Call Summary - Aug 13th, 2026 11:00 am
LENSAR® Reports Second Quarter 2026 Results and Provides Business Update - Aug 13th, 2026 5:00 am
LENSAR® to Report Second Quarter 2026 Results on August 13th, 2026 - Aug 6th, 2026 6:00 am
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now? - Jul 2nd, 2026 12:12 pm
How The LENSAR (LNSR) Story Is Shifting After The Failed Deal And New $10 Target - Jun 4th, 2026 2:14 pm
Lensar (LNSR) Q1 2026 Earnings Transcript - Jun 1st, 2026 11:10 am
Lensar (LNSR) Q4 2025 Earnings Transcript - Jun 1st, 2026 11:10 am
LENSAR Q1 Earnings Call Highlights - May 8th, 2026 12:20 pm
LENSAR® Reports First Quarter 2026 Results and Provides Business Update - May 8th, 2026 5:00 am
LENSAR® to Report First Quarter 2026 Results on May 8, 2026 - Apr 30th, 2026 5:00 am
How The Failed Alcon Deal Is Reframing The LENSAR (LNSR) Story And $10 Upside Potential - Apr 20th, 2026 11:03 pm
Cedar Grove Capital Management’s Views on LENSAR (LNSR) - Apr 20th, 2026 7:00 am
How The LENSAR (LNSR) Story Is Shifting After The Failed Alcon Deal And Target Reset - Apr 4th, 2026 6:18 pm
LENSAR Inc (LNSR) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges - Apr 3rd, 2026 7:00 pm
LENSAR, Inc. Q4 2025 Earnings Call Summary - Apr 1st, 2026 6:30 am